Home/Pipeline/Syndromic Test Portfolio

Syndromic Test Portfolio

Wide range of health conditions (screening, diagnosis, monitoring)

DevelopmentActive

Key Facts

Indication
Wide range of health conditions (screening, diagnosis, monitoring)
Phase
Development
Status
Active
Company

About miDiagnostics

miDiagnostics is a private, commercial-stage diagnostics company leveraging a disruptive silicon chip platform to deliver rapid, accurate, and low-cost molecular tests. Its integrated system consists of a single-use test card embedded with the chip, a portable reader, and supporting software, targeting a wide menu of syndromic conditions. With recent FDA clearance for an HSV-1&2 test and a focus on moving testing closer to the patient, the company is positioned to transform traditional lab-based diagnostics into rapid point-of-care solutions.

View full company profile

Therapeutic Areas